With reference to its earlier letter dated 12-Jun-24 on the inspection conducted by USFDA for its Manufacturing facility at Indrad, Gujarat from 03-Jun-24 to 12-Jun-24. In furtherance to the aforementioned intimation, Torrent Pharmaceuticals has informed that the USFDA has issued Establishment Inspection Report (‘EIR’) with Voluntary Action Indicated (‘VAI’) classification for the said manufacturing facility and the inspection has now been successfully closed by the USFDA.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1837.15 |
| Dr. Reddys Lab | 1271.55 |
| Cipla | 1353.85 |
| Zydus Lifesciences | 1070.90 |
| Lupin | 2351.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: